A total of 41 deals worth $6.15bn were announced in February 2019, compared to the 12-month average of 70 deals.
Venture financing was the leading category in the month in terms of volume with 31 deals which accounted for 75.6% of all deals.
In second place was M&A with nine deals, followed by private equity with one transactions, respectively accounting for 22% and 2.4% of overall deal activity in the country’s medical devices industry during the month.
In terms of value of deals, M&A was the leaging deal category in the US medical devices industry with total deals worth $5.85bn, while venture financing and private equity deals totalled $300.21m and $0m, respectively.
